This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eddy, S. F. Articles by Sonenshein, G. E. Search for Related Content PubMed PubMed Citation Articles by Eddy, S. F. Articles by Sonenshein, G. E.

Inducible IB Kinase/IB Kinase Expression Is Induced by CK2 and Promotes Aberrant Nuclear Factor-B Activation in Breast Cancer Cells

Departments of ¹ Biochemistry and ² Medicine and ³ the Women's Health Interdisciplinary Research Center, Boston University School of Medicine, Boston, Massachusetts

Requests for reprints: Gail E. Sonenshein, Department of Biochemistry, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118. Phone: 617-638-4120; Fax: 617-638-4252; E-mail: gsonensh{at}bu.edu.

Aberrant activation of nuclear factor-B (NF-B) transcription factors has been implicated in the pathogenesis of breast cancer. We previously showed elevated activity of IB kinase (IKK), IKKß, and protein kinase CK2 in primary human breast cancer specimens and cultured cells. A novel inducible IKK protein termed IKK-i/IKK has been characterized as a potential NF-B activator. Here, we provide evidence that implicates IKK-i/IKK in the pathogenesis of breast cancer. We show IKK-i/IKK expression in primary human breast cancer specimens and carcinogen-induced mouse mammary tumors. Multiple breast cancer cell lines showed higher levels of IKK-i/IKK and kinase activity compared with untransformed MCF-10F breast epithelial cells. Interestingly, IKK-i/IKK expression correlated with CK2 expression in mammary glands and breast tumors derived from MMTV-CK2 transgenic mice. Ectopic CK2 expression in untransformed cells led to increased IKK-i/IKK mRNA and protein levels. Inhibition of CK2 via the pharmacologic inhibitor apigenin or upon transfection of a CK2 kinase-inactive subunit reduced IKK-i/IKK levels. Expression of a kinase-inactive IKK-i/IKK mutant in breast cancer cells reduced NF-B activity as judged by transfection assays of reporters driven either by NF-B elements or the promoters of two NF-B target genes, cyclin D1 and relB. Importantly, the kinase-inactive IKK-i/IKK mutant reduced the endogenous levels of these genes as well as the ability of breast cancer cells to grow in soft agar or form invasive colonies in Matrigel. Thus, CK2 induces functional IKK-i/IKK, which is an important mediator of the activation of NF-B that plays a critical role in the pathogenesis of breast cancer. (Cancer Res 2005; 65(24): 11375-83)

This article has been cited by other articles:

				M. Zhang, X. Wu, A. J. Lee, W. Jin, M. Chang, A. Wright, T. Imaizumi, and S.-C. Sun Regulation of I{kappa}B Kinase-related Kinases and Antiviral Responses by Tumor Suppressor CYLD J. Biol. Chem., July 4, 2008; 283(27): 18621 - 18626. [Abstract] [Full Text] [PDF]

				K. Belguise, S. Guo, S. Yang, A. E. Rogers, D. C. Seldin, D. H. Sherr, and G. E. Sonenshein Green Tea Polyphenols Reverse Cooperation between c-Rel and CK2 that Induces the Aryl Hydrocarbon Receptor, Slug, and an Invasive Phenotype Cancer Res., December 15, 2007; 67(24): 11742 - 11750. [Abstract] [Full Text] [PDF]

				K. Belguise, S. Guo, and G. E. Sonenshein Activation of FOXO3a by the Green Tea Polyphenol Epigallocatechin-3-Gallate Induces Estrogen Receptor {alpha} Expression Reversing Invasive Phenotype of Breast Cancer Cells Cancer Res., June 15, 2007; 67(12): 5763 - 5770. [Abstract] [Full Text] [PDF]

				V. Giroux, J. Iovanna, and J.-C. Dagorn Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance FASEB J, October 1, 2006; 20(12): 1982 - 1991. [Abstract] [Full Text] [PDF]

				M. Adli and A. S. Baldwin IKK-i/IKK{epsilon} Controls Constitutive, Cancer Cell-associated NF-{kappa}B Activity via Regulation of Ser-536 p65/RelA Phosphorylation J. Biol. Chem., September 15, 2006; 281(37): 26976 - 26984. [Abstract] [Full Text] [PDF]